Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
about
Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniaeA Screen of FDA-Approved Drugs for Inhibitors of Zika Virus InfectionQuantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic reviewStructure determination of the functional domain interaction of a chimeric nonribosomal peptide synthetase from a challenging crystal with noncrystallographic translational symmetryStructure of the Bacterial Deacetylase LpxC Bound to the Nucleotide Reaction Product Reveals Mechanisms of Oxyanion Stabilization and Proton TransferStrain Dependent Genetic Networks for Antibiotic-Sensitivity in a Bacterial Pathogen with a Large Pan-GenomeIdentification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater Cyanobacterium Trichormus sp. UIC 10339.Bioprospecting microbial natural product libraries from the marine environment for drug discovery.Screen for inducers of autolysis in Bacillus subtilisAttenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitisGenetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibioticsMetabolic engineering for the production of natural products.High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case reportIdentification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteinsTransposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents.Emerging knowledge of regulatory roles of D-amino acids in bacteria.New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium speciesTotal syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptideCharacterization of d-boroAla as a novel broad-spectrum antibacterial agent targeting d-Ala-d-Ala ligase.A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin.Topological and mutational analysis of Saccharomyces cerevisiae Fks1Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.Bacterial strategies of resistance to antimicrobial peptides.Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infectionsTranscriptional analysis of the effect of exogenous decanoic acid stress on Streptomyces roseosporus.Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.Cardiolipin prevents membrane translocation and permeabilization by daptomycin.Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics.Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machineryProkaryotic gene clusters: a rich toolbox for synthetic biology.Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids.Regulation mechanisms underlying the biosynthesis of daptomycin and related lipopeptides.Bacterial meningitis: current therapy and possible future treatment options.Recent derivatives from smaller classes of fermentation-derived antibacterials.Prospects for new antibiotics: a molecule-centered perspective.
P2860
Q24656785-7E42278E-1B83-47DC-A236-333009809CE6Q26252076-3314CF51-55E9-419B-BDD5-EF2946078E87Q26796165-F9CC9A82-E8D5-4B02-9D81-8760980C187AQ27679256-46008976-EBF5-4899-960D-ABB887AEE9C6Q27680209-64E4B584-B212-4548-A8B2-6B5893D686D2Q28553946-7615E798-FDC1-4224-B7DE-28F04BD46216Q30394525-622207A2-340D-4CA6-BAD7-2B5F44442497Q30840534-3CFEAE18-9B93-4D81-9395-FDA1BE52768DQ30985377-7BE89B58-64F1-40FF-A73E-F17FEABD3CEBQ33626330-74260FB8-B072-4079-9A6C-69D08CA85F62Q33676211-F4F8EF19-00C3-43BA-99D1-B6C9A769E753Q33768851-158FB83A-852E-4CD4-9DD4-503E724CCB51Q33798586-9C13DC55-23A4-492B-87CE-1A837BE34DE5Q33829836-AA2305CB-76DB-418B-8CC0-97DDDE516E1FQ33911941-39D26447-F53F-465A-AAEB-7911F8C95010Q34022733-BF52B722-4530-4C6B-8630-04A7F9C3B04DQ34278802-DE1D23A2-4DAA-42AD-A0CC-25013753B281Q34436348-FA214100-F81E-49CB-BA52-681C6BC222CEQ34567849-B1B14F46-D145-4A14-B158-7F4A272B52C1Q35139501-D87C2273-B26F-4996-B084-17BB1A6C9ADEQ35224649-8BC5FCB9-B036-44A6-804C-66FA255C30DEQ35350437-9DD6337C-4552-4F3F-980C-B87964A32013Q36061532-04C77150-AAC1-4F64-8BCD-8AF6525A38FDQ36156130-4901ADD1-E04E-4F6C-B75A-A599E0B332D1Q36171566-E53AFA32-1150-4BD5-A11B-BF98F4B0EC9CQ36396117-ED378C62-F47A-4906-8188-C4DEE45F984DQ36565462-1D67E95D-3A59-4C51-96AB-9A2B58878514Q36920921-A050B2A4-754D-452B-96B3-0DD95C509FFDQ36927625-8B7DEAA0-B000-4B8E-BD14-15A130975C05Q37047900-999C3CD4-D4F7-4CE4-9EFD-EF22325D4C3CQ37538754-E7E9E127-0CDF-41CE-B687-654E66F46C37Q37727568-48ACA0D4-6D39-46CB-B7AC-DC7F551F099DQ37735905-79518CC7-4796-4F2D-AABD-FCC9AA721C36Q37762644-50D2F690-3AD9-48C4-9DA2-E4FD916D7B2EQ37820597-6B0336BA-E6DD-47C5-89F8-9F9B6B051E6FQ37838487-11C68860-5CF5-496E-BDD7-D5F88A3E975AQ37948673-3515228C-7D4E-4913-BD69-6D0F7093EB3DQ37949641-DA9C3722-E75A-4354-956C-776A150A25E8Q37964009-888996B5-3004-4AC0-A074-6A66EA5F1602Q38113689-6083A1BE-DA44-47A0-8307-D267B4FB8120
P2860
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@ast
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@en
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@nl
type
label
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@ast
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@en
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@nl
prefLabel
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@ast
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@en
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@nl
P1476
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
@en
P2093
Richard H Baltz
P304
P356
10.1016/J.CBPA.2009.02.031
P577
2009-03-19T00:00:00Z